Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
VRDN:NASDAQ
Viridian Therapeutics Inc
$13.50
-1.64%
(-0.23) 1D
$13.50
0.00% (0.00)
After hours
Closed: Apr 27, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRDN...
Open
$13.68
High
$13.92
Low
$13.32
Mkt. cap
1.39B
Avg. vol.
2.89M
Volume
2.28M
52-wk high
$34.29
52-wk low
$11.76
EPS
-$4.04
Beta
1.17
Shares outstanding
102.21M
No. of employees
252
News stories
From sources across the web
About Viridian Therapeutics Inc
CEO-
Employees252
Founded2010
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
72.00K
75.00K
70.57M
132.00K
Cost of goods sold
5.75M
86.63M
86.26M
92.71M
Cost of revenue
5.75M
86.63M
86.26M
92.71M
Research and development expenses
71.09M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.10M
20.22M
24.32M
33.67M
Operating expense
88.19M
20.22M
24.32M
33.67M
Total operating expenses
93.94M
106.84M
110.58M
126.38M
Operating income
-93.87M
-106.77M
-40.01M
-126.25M
Other non operating income
-
-
453.00K
-2.12M
EBT including unusual items
-86.91M
-100.74M
-34.60M
-120.36M
EBT excluding unusual items
-86.91M
-100.74M
-34.60M
-123.86M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-86.91M
-100.74M
-34.60M
-120.36M
Net profit margin
-120,711.11%
-134,313.33%
-49.03%
-91,178.03%
Earnings per share
-0.87
-1.00
-0.34
-1.08
Interest and investment income
7.54M
6.55M
5.52M
7.79M
Interest expense
-586.00K
-514.00K
-560.00K
-3.28M
Net interest expenses
6.95M
6.03M
4.96M
4.51M
Depreciation and amortization charges
-
-
-
-
EBITDA
-93.75M
-106.65M
-39.90M
-126.13M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more